AUGMENTATION OF HYPOXIC PULMONARY VASOCONSTRICTION IN THE ISOLATED PERFUSED RAT LUNG BY INVITRO ANTAGONISTS OF ENDOTHELIUM-DEPENDENT RELAXATION
AUGMENTATION OF HYPOXIC PULMONARY VASOCONSTRICTION IN THE ISOLATED PERFUSED RAT LUNG BY INVITRO ANTAGONISTS OF ENDOTHELIUM-DEPENDENT RELAXATION
复制标题
DOI:
10.1172/jci113757
复制
发表时间:
1988-11-01
影响因子:
15.9
通讯作者:
ROSE, CE
中科院分区:
文献类型:
--
作者:
BRASHERS, VL;PEACH, MJ;ROSE, CE
The role of the endothelium in hypoxic constriction of the intact pulmonary vascular bed has not been clearly elucidated. To test for a possible role for endothelium-derived relaxing factor(s) (EDRF) in the hypoxic pressor response, isolated, whole blood-perfused rat lungs from male Sprague-Dawley rats treated with meclofenamate were prepared. Three protocols were performed, including: (a) normal saline (control); (b) the putative EDRF inhibitors, eicosatetraynoic acid (ETYA, 1 .times. 10-4 M) or nordihydroguaiaretic acid (NDGA, 1 .times. 10-4 M) versus vehicle DMSO; and (c) the putative EDRF inhibitor hydroquinone (HQ, 1 .times. 10-4 M) versus vehicle ethyl alcohol (ETOH). The pulmonary pressor response to angiotensin II (Ang II, 0.25 .mu.g) injections alternated with 6-min periods of hypoxic ventilation (3% O2, 5% CO2) was measured before and after the administration of saline, inhibitors, or vehicles. The administration of the EDRF inhibitors ETYA, NDGA, and HQ resulted in a marked accentuation of the hypoxic pressor response that was not seen in the controls (P < 0.05). In separate experiments, lungs precontracted with norepinephrine (1 .times. 10-6 M) were pretreated with edrophonium (1 .times. 10-4 M) and then observed for endothelium-dependent vasodilator responses to acetylcholine at increasing doese (1 .times. 10-7-1 .times. 10-4 M). Administration of ETYA, NDGA, or HQ abrogated the observed vasodilatation to acetylcholine, which was not seen with vehicles alone (P < 0.01). These studies suggest an important role for the endothelium in pulmonary vascular responsiveness to alveolar hypoxia through possible release of a relaxing factor(s) that attenuates the degree of pulmonary arterial constriction.